Resultats globals: 15 registres trobats en 0.02 segons.
Articles, 15 registres trobats
Articles 15 registres trobats  1 - 10següent  anar al registre:
1.
12 p, 783.3 KB Genetic correlation between amyotrophic lateral sclerosis and schizophrenia / McLaughlin, Russell L. (Trinity College Dublin) ; Schijven, Dick (University Medical Center Utrecht) ; van Rheenen, Wouter (University Medical Center Utrecht) ; Van Eijk, Kristel R. (University Medical Center Utrecht) ; O'Brien, Margaret (Trinity College Dublin) ; Kahn, René S. (University Medical Center Utrecht) ; Ophoff, Roel A. (University of California) ; Goris, An (KU Leuven-University of Leuven) ; Bradley, Daniel G. (Trinity College Dublin) ; Al-Chalabi, Ammar (King's College London) ; van den Berg, Leonard H. (University Medical Center Utrecht) ; Luykx, Jurjen J. (Hospital Network Antwerp (ZNA). Stuivenberg and Sint Erasmus) ; Hardiman, Orla (Trinity College Dublin) ; Veldink, Jan (University Medical Center Utrecht) ; Shatunov, Aleksey (King's College London) ; Dekker, Annelot M. (University Medical Center Utrecht) ; Diekstra, Frank P. (University Medical Center Utrecht) ; Pulit, Sara L. (University Medical Center Utrecht) ; van der Spek, Rick A.A. (University Medical Center Utrecht) ; van Doormaal, Perry TC. (University Medical Center Utrecht) ; Sproviero, William (King's College London) ; Jones, Ashley R. (King's College London) ; Nicholson, Garth A. (University of Sydney) ; Rowe, Dominic B. (Macquarie University) ; Pamphlett, Roger (University of Sydney) ; Kiernan, Matthew C. (University of Sydney) ; Bauer, Denis (Commonwealth Scientific and Industrial Research Organisation) ; Kahlke, Tim (Commonwealth Scientific and Industrial Research Organisation) ; Williams, Kelly (Macquarie University) ; Eftimov, Filip (Academic Medical Center) ; Fogh, Isabella (IRCCS Istituto Auxologico Italiano) ; Ticozzi, Nicola (Università degli Studi di Milano) ; Lin, Kuang (King's College London) ; Millecamps, Stéphanie (Institut du Cerveau et de la Moelle Épinière) ; Salachas, François (Ramsay Generale de Santé) ; Meininger, Vincent (Ramsay Generale de Santé) ; de Carvalho, Mamede (Hospital de Santa Maria (Lisboa)) ; Pinto, Susana (Hospital de Santa Maria (Lisboa)) ; Mora, Jesús S. (Hospital Carlos III (Madrid)) ; Rojas-Garcia, Ricard (Institut d'Investigació Biomèdica Sant Pau) ; Polak, Meraida (Emory University) ; Chandran, Siddharthan (University of Edinburgh) ; Colville, Shuna (Euan MacDonald Centre for Motor Neurone Disease Research) ; Swingler, Robert (Euan MacDonald Centre for Motor Neurone Disease Research) ; Morrison, Karen E. (Queen Elizabeth Hospital) ; Shaw, Pamela (University of Sheffield) ; Hardy, John (University College London) ; Orrell, Richard W. (University College London) ; Pittman, Alan (University College London) ; Sidle, Katie (University College London) ; Fratta, Pietro (University College London) ; Malaspina, Andrea (Motor Neuron Disease Care Centre) ; Petri, Susanne (Medical School Hannover) ; Abdulla, Susanne (Otto-von-Guericke University Magdeburg) ; Drepper, Carsten (University of Würzburg) ; Sendtner, Michael (University of Würzburg) ; Meyer, Thomas (Charité University Hospital) ; Wiedau-Pazos, Martina (University of California) ; Lomen-Hoerth, Catherine (University of California) ; van Deerlin, Vivianna M. (University of Pennsylvania) ; Trojanowski, John Q. (University of Pennsylvania) ; Elman, Lauren B. (University of Pennsylvania) ; McCluskey, Leo (University of Pennsylvania) ; Basak, Nazli (Bogazici University) ; Meitinger, Thomas (Helmholtz Zentrum München) ; Lichtner, Peter (Helmholtz Zentrum München) ; Blagojevic-Radivojkov, Milena (Helmholtz Zentrum München) ; Andres, Christian R. (Université François Rabelais) ; Maurel, Cindy (Université François Rabelais) ; Bensimon, Gilbert (Hôpital de la Pitié-Salpêtrière) ; Landwehrmeyer, Georg Bernhard (Ulm University) ; Brice, Alexis (Sorbonne Universités) ; Payan, Christine A. M. (Hôpital de la Pitié-Salpêtrière) ; Saker-Delye, Safa (Genethon. CNRS UMR 8587) ; Durr, Alexandra (Hoptial Salpêtrière) ; Wood, Nicholas (University College London) ; Tittmann, Lukas (Christian Albrechts-University Kiel) ; Lieb, Wolfgang (Christian Albrechts-University Kiel) ; Franke, Andre (Kiel University) ; Rietschel, Marcella (Central Institute of Mental Health) ; Cichon, Sven (Research Center Juelich) ; Nothen, Markus M. (Life and Brain Center) ; Amouyel, Philippe (Institut Pasteur de Lille) ; Tzourio, Christophe (Pole de Sante Publique) ; Dartigues, Jean- François (Pole de Sante Publique) ; Uitterlinden, André G. (Erasmus Medical Center Rotterdam) ; Rivadeneira, Fernando (Erasmus Medical Center Rotterdam) ; Estrada, Karol (Erasmus Medical Center Rotterdam) ; Hofman, Albert (Erasmus Medical Center Rotterdam) ; Curtis, Charles (King's College London) ; van der kooi, Anneke Jelly (Academic Medical Center) ; de Visser, Marianne (Academic Medical Center) ; Weber, Markus (ALS Clinic) ; Shaw, Christopher (King's College London) ; Smith, B.N. (King's College London) ; Pansarasa, O. (IRCCS 'C. Mondino' National Institute) ; Cereda, C. (IRCCS 'C. Mondino' National Institute) ; Bo, R.D. (IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico) ; Comi, G.P. (IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico) ; D'Alfonso, S. (Università Del Piemonte Orientale) ; Bertolin, C. (University of Padova) ; Soraru, G. (University of Padova) ; Mazzini, L. (University of Eastern Piedmont) ; Pensato, V. (Fondazione IRCCS Istituto Neurologico 'Carlo Besta') ; Gellera, C. (Fondazione IRCCS Istituto Neurologico 'Carlo Besta') ; Tiloca, C. (IRCCS Istituto Auxologico Italiano) ; Ratti, A. (Università degli Studi di Milano) ; Calvo, A. (Azienda Ospedaliera Città della Salute e della Scienza) ; Moglia, C. (Azienda Ospedaliera Città della Salute e della Scienza) ; Brunetti, M. (Azienda Ospedaliera Città della Salute e della Scienza) ; Arcuti, S. (University of Bari 'A. Moro') ; Capozzo, Rosa (University of Bari 'A. Moro') ; Zecca, C. (University of Bari 'A. Moro') ; Lunetta, C. (Niguarda Ca' Granda Hostipal) ; Penco, S. (Niguarda Ca' Granda Hospital) ; Riva, N. (San Raffaele Scientific Institute) ; Padovani, A. (University Hospital 'Spedali Civili') ; Filosto, M. (University Hospital 'Spedali Civili') ; Blair, I. (Macquarie University) ; Nigel Leigh, P. (Brighton and Sussex Medical School) ; Casale, F. ('Rita Levi Montalcini') ; Chio, A. (Azienda Ospedaliera Città della Salute e della Scienza) ; Beghi, E. (IRCCS Istituto di Ricerche Farmacologiche Mario Negri) ; Pupillo, E. (IRCCS Istituto di Ricerche Farmacologiche Mario Negri) ; Tortelli, R. (University of Bari 'A. Moro') ; Logroscino, G. (University of Bari 'Aldo Moro') ; Powell, J. (King's College London) ; Ludolph, A.C. (Ulm University) ; Weishaupt, J.H. (Ulm University) ; Robberecht, W. (University Hospital Leuven) ; Damme, P.V. (VIB-Vesalius Research Center) ; Brown, R. H. (University of Massachusetts Medical School) ; Glass, J. (Emory University) ; Landers, J.E. (University of Massachusetts Medical School) ; Andersen, P.M. (Umeå University) ; Corcia, P. (Federation des Centres SLA Tours and Limoges) ; Vourc'H, P. (Université François Rabelais) ; Silani, V. (Università degli Studi di Milano) ; Es, M.A.V. (University Medical Center Utrecht) ; Pasterkamp, R.J. (University Medical Center Utrecht) ; Lewis, C.M. (King's College London) ; Breen, G. (King's College London) ; Ripke, S. (Broad Institute of MI.T. and Harvard) ; Neale, B.M. (Massachusetts General Hospital) ; Corvin, A. (Trinity College) ; Walters, J.T.R. (Cardiff University) ; Farh, K.H. (Massachusetts General Hospital) ; Holmans, P.A. (Cardiff University) ; Lee, P. (Massachusetts General Hospital) ; Bulik-Sullivan, B. (Broad Institute of MI.T. and Harvard) ; Collier, D.A. (King's College London) ; Huang, H. (Broad Institute of MI.T. and Harvard) ; Pers, T.H. (Boston Children's Hospital (Boston, Estats Units d'Amèrica)) ; Agartz, I. (University of Oslo) ; Agerbo, Esben (Lundbeck Foundation Initiative for Integrative Psychiatric Research) ; Albus, M. (State Mental Hospital) ; Alexander, M. (Stanford University) ; Amin, F. (Emory University) ; Bacanu, S.A. (Virginia Commonwealth University) ; Begemann, M. (Max Planck Institute of Experimental Medicine) ; Belliveau, R.A. (Broad Institute of MI.T. and Harvard) ; Bene, J. (University of Pécs) ; Bergen, Sarah E. (Karolinska Institutet (Estocolm, Suècia)) ; Bevilacqua, E. (Broad Institute of MI.T. and Harvard) ; Bigdeli, Tim B (Virginia Commonwealth University) ; Black, D.W. (University of Iowa) ; Bruggeman, R. (University Medical Center Groningen) ; Buccola, N.G. (Louisiana State University Health Sciences Center) ; Buckner, R.L. (Massachusetts General Hospital) ; Byerley, W. (University of California at San Francisco) ; Cahn, Wiepke (University Medical Center Utrecht) ; Cai, G. (Icahn School of Medicine at Mount Sinai) ; Campion, D. (Centre Hospitalier du Rouvray) ; Cantor, R.M. (University of California) ; Carr, Vaughan J (University of New South Wales) ; Carrera, N. (Cardiff University) ; Catts, S.V. (University of Queensland) ; Chambert, K.D. (Broad Institute of MI.T. and Harvard) ; Chan, R.C.K. (Chinese Academy of Science) ; Chan, R.Y.L. (University of Hong Kong) ; Chen, E.Y.H. (University of Hong Kong) ; Cheng, W. (University of North Carolina) ; Cheung, E.F.C. (Castle Peak Hospital) ; Chong, S.A. (Institute of Mental Health) ; Cloninger, C.R. (Washington University) ; Cohen, D. (Brain and Spinal Cord Institute (ICM)) ; Cohen, N. (Janssen Research and Development. LLC) ; Cormican, P. (Trinity College) ; Craddock, N. (Cardiff University) ; Crowley, J.J. (University of North Carolina) ; Curtis, D. (University College London) ; Davidson, M. (Sheba Medical Center) ; Davis, K.L. (Icahn School of Medicine at Mount Sinai) ; Degenhardt, F. (Life and Brain Center) ; Favero, J.D. (University of Antwerp) ; Demontis, D. (Aarhus University) ; Dikeos, D. (University of Athens Medical School) ; Dinan, T. (University College Cork) ; Djurovic, S. (Oslo University Hospital) ; Donohoe, G. (National University of Ireland) ; Drapeau, E. (Icahn School of Medicine at Mount Sinai) ; Duan, J. (NorthShore University HealthSystem) ; Dudbridge, F. (London School of Hygiene and Tropical Medicine) ; Durmishi, N. (University Clinic of Psychiatry) ; Eichhammer, P. (University of Regensburg) ; Eriksson, J. (National Institute for Health and Welfare) ; Escott-Price, V. (Cardiff University) ; Essioux, L. (Pharma Research and Early Development) ; Fanous, A.H. (Washington V.A. Medical Center) ; Farrell, M.S. (University of North Carolina) ; Frank, J. (University of Heidelberg) ; Franke, L. (University Medical Centre Groningen) ; Freedman, R. (University of Colorado Denver) ; Freimer, N.B. (University of California) ; Friedl, M. (University of Halle) ; Friedman, J.I. (Icahn School of Medicine at Mount Sinai) ; Fromer, M. (Icahn School of Medicine at Mount Sinai) ; Genovese, G. (Broad Institute of MI.T. and Harvard) ; Georgieva, L. (Cardiff University) ; Giegling, I. (University of Munich) ; Giusti-Rodrýguez, P. (University of North Carolina) ; Godard, S. (Hôpital de la Pitiè-Salpêtrière) ; Goldstein, J.I. (Broad Institute of MI.T. and Harvard) ; Golimbet, V. (Russian Academy of Medical Sciences) ; Gopal, S. (Janssen Research and Development. LLC) ; Gratten, J. (University of Queensland) ; De Haan, L. (University of Amsterdam) ; Hammer, C. (Max Planck Institute of Experimental Medicine) ; Hamshere, M.L. (Cardiff University) ; Hansen, M. (Illumina. Inc.) ; Hansen, T. (Institute of Biological Psychiatry) ; Haroutunian, V. (JJ Peters V.A. Medical Center) ; Hartmann, A.M. (University of Halle) ; Henskens, F.A. (University of Newcastle) ; Herms, S. (University of Basel) ; Hirschhorn, J.N. (Harvard Medical School) ; Hoffmann, P. (University of Basel) ; Hofman, A. (Erasmus Medical Center Rotterdam) ; Hollegaard, M.V. (Statens Serum Institut) ; Hougaard, D.M. (Statens Serum Institut) ; Ikeda, M. (Fujita Health University) ; Joa, I. (Stavanger University Hospital) ; Julia, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Kalaydjieva, L. (University of Western Australia) ; Karachanak-Yankova, S. (Medical University) ; Karjalainen, J. (University Medical Centre Groningen) ; Kavanagh, D. (Cardiff University) ; Keller, M.C. (University of Colorado Boulder) ; Kennedy, J.L. (University of Toronto) ; Khrunin, A. (Russian Academy of Sciences) ; Kim, Y. (University of North Carolina) ; Klovins, J. (Latvian Biomedical Research and Study Centre) ; Knowles, J.A. (University of Southern California) ; Konte, B. (University of Halle) ; Kucinskas, V. (Vilnius University) ; Kucinskiene, Z.A. (Vilnius University) ; Kuzelova-Ptackova, H. (Charles University Prague) ; Kahler, A.K. (Karolinska Institutet (Estocolm, Suècia)) ; Laurent, C. (Pierre and Marie Curie Faculty of Medicine) ; Lee, J. (Duke-NUS Graduate Medical School) ; Hong Lee, S. (University of Queensland) ; Legge, S.E. (Cardiff University) ; Lerer, B. (Hadassah-Hebrew University Medical Center) ; Li, M. (University of Hong Kong) ; Li, T. (Sichuan University) ; Liang, K.Y. (Bloomberg School of Public Health) ; Lieberman, J. (Columbia University) ; Limborska, S. (Russian Academy of Sciences) ; Loughland, C.M. (University of Newcastle) ; Lubinski, J. (Pomeranian Medical University in Szczecin) ; Lonnqvist, J. (National Institute for Health and Welfare) ; MacEk, M. (Charles University Prague) ; Magnusson, P.K.E. (Karolinska Institutet (Estocolm, Suècia)) ; Maher, B.S. (Johns Hopkins University) ; Maier, W. (University of Bonn) ; Mallet, J. (Hôpital de la Pitié Salpêtrière) ; Marsal, Sara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Mattheisen, M. (University of Bonn) ; Mattingsdal, M. (Sørlandet Hospital) ; McCarley, R.W. (Virginia Boston Health Care System) ; McDonald, C. (National University of Ireland) ; McIntosh, A.M. (University of Edinburgh) ; Meier, S. (University of Heidelberg) ; Meijer, C.J. (University of Amsterdam) ; Melegh, B. (University of Pécs) ; Melle, I. (Oslo University Hospital) ; Mesholam-Gately, R.I. (Beth Israel Deaconess Medical Center) ; Metspalu, A. (University of Tartu) ; Michie, P.T. (University of Newcastle) ; Milani, L. (University of Tartu) ; Milanova, V. (First Psychiatric Clinic) ; Mokrab, Y. (Eli Lilly and Company Limited) ; Morris, D.W. (National University of Ireland) ; Mors, O. (Aarhus University Hospital (Aarhus, Dinamarca)) ; Murphy, K.C. (Royal College of Surgeons in Ireland) ; Murray, R.M. (King's College London) ; Myin-Germeys, I. (Maastricht University Medical Centre) ; Muller-Myhsok, B. (Munich Cluster for Systems Neurology (SyNergy)) ; Nelis, M. (University of Tartu) ; Nenadic, I. (Jena University Hospital) ; Nertney, D.A. (University of Queensland) ; Nestadt, G. (Johns Hopkins University) ; Nicodemus, K.K. (Trinity College Dublin) ; Nikitina-Zake, L. (Latvian Biomedical Research and Study Centre) ; Nisenbaum, L. (Lilly Corporate Center) ; Nordin, A. (Umeå University) ; O'Callaghan, E. (Early Intervention Service for Psychosis) ; O'Dushlaine, C. (Broad Institute of MI.T. and Harvard) ; Anthony O'Neill, F. (Queens University Belfast) ; Oh, S.Y. (University of California at Berkeley) ; Olincy, A. (University of Colorado Denver) ; Olsen, L. (Institute of Biological Psychiatry) ; Vanos, J. (King's College London) ; Pantelis, C. (University of Melbourne and Melbourne Health) ; Papadimitriou, G.N. (University of Athens Medical School) ; Papiol, S. (Max Planck Institute of Experimental Medicine) ; Parkhomenko, E. (Icahn School of Medicine at Mount Sinai) ; Pato, M.T. (University of Southern California) ; Paunio, T. (National Institute for Health and Welfare) ; Pejovic-Milovancevic, M. (University of Belgrade) ; Perkins, D.O. (University of North Carolina) ; Pietilainen, O. (Institute for Molecular Medicine Finland) ; Pimm, J. (University College London) ; Pocklington, A.J. (Cardiff University) ; Price, A. (Harvard University) ; Pulver, A.E. (Johns Hopkins University) ; Purcell, S.M. (Icahn School of Medicine at Mount Sinai) ; Quested, D. (University of Oxford) ; Rasmussen, H.B. (Institute of Biological Psychiatry) ; Reichenberg, A. (Icahn School of Medicine at Mount Sinai) ; Reimers, M.A. (Virginia Commonwealth University) ; Richards, A.L. (Cardiff University) ; Roffman, J.L. (Massachusetts General Hospital) ; Roussos, P. (Icahn School of Medicine at Mount Sinai) ; Ruderfer, D.M. (Icahn School of Medicine at Mount Sinai) ; Salomaa, V. (National Institute for Health and Welfare) ; Sanders, A.R. (NorthShore University HealthSystem) ; Schall, U. (University of Newcastle) ; Schubert, C.R. (Pfizer Worldwide Research and Development) ; Schulze, T.G. (University of Gottingen) ; Schwab, S.G. (University of Erlangen) ; Scolnick, E.M. (Broad Institute of MI.T. and Harvard) ; Scott, R.J. (University of Newcastle) ; Seidman, L.J. (Beth Israel Deaconess Medical Center) ; Shi, J. (National Cancer Institute) ; Sigurdsson, E. (University of Iceland) ; Silagadze, T. (Tbilisi State Medical University (TSMU)) ; Silverman, J.M. (Bronx Veterans Affairs Medical Center) ; Sim, K. (Institute of Mental Health) ; Slominsky, P. (Russian Academy of Sciences) ; Smoller, J.W. (Massachusetts General Hospital) ; So, H.C. (University of Hong Kong) ; Spencer, C.C.A. (Wellcome Trust Centre for Human Genetics) ; Stah, E.A. (Icahn School of Medicine at Mount Sinai) ; Stefansson, H. (DeCODE Genetics) ; Steinberg, S. (DeCODE Genetics) ; Stogmann, E. (Medical University of Vienna) ; Straub, R.E. (Lieber Institute for Brain Development) ; Strengman, E. (University Medical Centre Utrecht) ; Strohmaier, J. (University of Heidelberg) ; Scott Stroup, T. (Columbia University) ; Subramaniam, M. (Institute of Mental Health) ; Suvisaari, J. (Institute for Health and Welfare) ; Svrakic, D.M. (Washington University) ; Szatkiewicz, J.P. (University of North Carolina) ; Söderman, E. (Karolinska Institutet (Estocolm, Suècia)) ; Thirumalai, S. (Berkshire Healthcare NH.S. Foundation Trust) ; Toncheva, D. (Medical University) ; Tosato, S. (University of Verona) ; Veijola, J. (University Hospital of Oulu) ; Waddington, J. (Royal College of Surgeons in Ireland) ; Walsh, D. (Health Research Board) ; Wang, D. (Janssen Research and Development) ; Wang, Q. (Sichuan University) ; Webb, B.T. (Virginia Commonwealth University) ; Weiser, Mark (Sheba Medical Center) ; Wildenauer, Dieter B. (Queen Elizabeth I.I. Medical Centre) ; Williams, Nigel M. (Cardiff University) ; Williams, Stephanie (University of North Carolina) ; Witt, Stephanie H. (University of Heidelberg) ; Wolen, Aaron R. (Virginia Commonwealth University) ; Wong, Emily H. M. (University of Hong Kong) ; Wormley, Brandon K. (Virginia Commonwealth University) ; Xi, Hualin S. (Pfizer Worldwide Research and Development) ; Zai, Clement C. (University of Toronto) ; Zheng, Xuebin (Genome Institute of Singapore) ; Zimprich, Fritz (University of Vienna) ; Wray, Naomi R. (University of Queensland) ; Stefánsson, Kári (DeCODE Genetics) ; Visscher, PM (University of Queensland) ; Adolfsson, Rolf (Umeå University) ; Andreassen, Ole A. (Oslo University Hospital) ; Blackwood, Douglas H. R. (University of Edinburgh) ; Bramon, Elvira (University College London) ; Buxbaum, Joseph D. (Icahn School of Medicine at Mount Sinai) ; Børglum, Anders D. (Aarhus University Hospital (Aarhus, Dinamarca)) ; Darvasi, Ariel (Hebrew University of Jerusalem) ; Domenici, Enrico (F. Hoffman-La Roche) ; Ehrenreich, Hannelore (Max Planck Institute of Experimental Medicine) ; Esko, Tõnu (University of Tartu) ; Gejman, Pablo V. (NorthShore University HealthSystem) ; Gil, Michael (Trinity College) ; Gurling, Hugh (University College London) ; Hultman, Christina M. (Karolinska Institutet (Estocolm, Suècia)) ; Iwata, Nakao (Fujita Health University) ; Jablensky, Assen V. (UWA Centre for Clinical Research in Neuropsychiatry) ; Jonsson, Erik G. (Karolinska Institutet (Estocolm, Suècia)) ; Kendler, Kenneth S. (Virginia Commonwealth University) ; Kirov, George (Cardiff University) ; Knight, Jo (University of Toronto) ; Lencz, Todd (Zucker Hillside Hospital) ; Levinson, Douglas F. (Stanford University) ; Li, Qingqin S. (Janssen Research and Development) ; Liu, Jianjun (National University of Singapore) ; Malhotra, Anil K. (Zucker Hillside Hospital) ; McCarroll, Steven A. (Harvard Medical School) ; McQuillin, Andrew (University College London) ; Moran, Jennifer (Broad Institute of MI.T. and Harvard) ; Mortensen, Preben Bo (Lundbeck Foundation Initiative for Integrative Psychiatric Research) ; Mowry, Bryan J. (University of Queensland) ; Owen, Michael J. (Cardiff University) ; Palotie, Aaron (Broad Institute of MI.T. and Harvard) ; Pato, Carlos N. (University of Southern California) ; Petryshen, Tracey L. (Massachusetts General Hospital) ; Posthuma, Danielle (Vrije Universiteit Amsterdam) ; Riley, Brien Patrick (Virginia Commonwealth University) ; Rujescu, Dan (University of Munich) ; Sham, Pak C. (University of Hong Kong) ; Sklar, Pamela (Icahn School of Medicine at Mount Sinai) ; St Clair, David (University of Aberdeen) ; Weinberger, Daniel R. (Johns Hopkins School of Medicine) ; Wendland, Jens (Pfizer Worldwide Research and Development) ; Werge, Thomas (University of Copenhagen) ; Daly, Mark J. (Massachusetts General Hospital) ; Sullivan, Patrick F. (University of North Carolina) ; O'Donovan, Michael C. (Cardiff University) ; Universitat Autònoma de Barcelona
We have previously shown higher-than-expected rates of schizophrenia in relatives of patients with amyotrophic lateral sclerosis (ALS), suggesting an aetiological relationship between the diseases. Here, we investigate the genetic relationship between ALS and schizophrenia using genome-wide association study data from over 100,000 unique individuals. [...]
2017 - 10.1038/ncomms14774
Nature communications, Vol. 8 (21 2017) , p. 14774  
2.
13 p, 527.1 KB Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosis / Kontaxis, Spyridon (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Laporta, Estela (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Garcia, Esther (Universitat Autònoma de Barcelona. Departament de Microelectrònica i Sistemes Electrònics) ; Guerrero, Ana Isabel (Hospital Universitari Vall d'Hebron) ; Zabalza, Ana (Hospital Universitari Vall d'Hebron) ; Matteo, Martinis (Vita Salute San Raffaele University) ; Lucia, Roselli (Vita Salute San Raffaele University) ; Simblett, Sara (King's College London) ; Weyer, Janice (RADAR-CNS Patient Advisory Board) ; Hotopf, Matthew (King's College London) ; Narayan, Vaibhav A. (Research and Development Information Technology) ; Rashid, Zulqarnain (King's College London) ; Folarin, Amos A. (University College London) ; Dobson, Richard J. B. (University College London) ; Buron, Mathias Due (Copenhagen University Hospital Rigshospitalet) ; Leocani, Letizia (Vita Salute San Raffaele University) ; Cummins, Nicholas (King's College London) ; Vairavan, Srinivasan (Research and Development Information Technology) ; Costa, Gloria Dalla (Vita Salute San Raffaele University) ; Magyari, Melinda (Copenhagen University Hospital Rigshospitalet) ; Sørensen, Per Soelberg (Copenhagen University Hospital Rigshospitalet) ; Nos, Carlos (Hospital Universitari Vall d'Hebron) ; Bailón, Raquel (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Comi, Giancarlo (Casa di Cura del Policlinico (Milà, Itàlia)) ; the RADAR-CNS Consortium, None (The RADAR-CNS Consortium)
The aim of this study was to evaluate the association between changes in the autonomic control of cardiorespiratory system induced by walk tests and outcome measures in people with Multiple Sclerosis (pwMS). [...]
2023 - 10.3389/fphys.2023.1145818
Frontiers in physiology, Vol. 14 (april 2023)  
3.
11 p, 732.4 KB Automatic Assessment of the 2-Minute Walk Distance for Remote Monitoring of People with Multiple Sclerosis / Kontaxis, Spyridon (Universidad de Zaragoza) ; Laporta, Estela (Universidad de Zaragoza) ; Garcia, Esther (Universitat Autònoma de Barcelona. Departament de Microelectrònica i Sistemes Electrònics) ; Martinis, Matteo (University Vita-Salute and Hospital San Raffaele) ; Leocani, Letizia (University Vita-Salute and Hospital San Raffaele) ; Roselli, Lucia (University Vita-Salute and Hospital San Raffaele) ; Buron, Mathias Due (Copenhagen University Hospital Rigshospitalet) ; Guerrero, Ana Isabel (Hospital Universitari Vall d'Hebron) ; Zabalza, Ana (Hospital Universitari Vall d'Hebron) ; Cummins, Nicholas (King's College London) ; Vairavan, Srinivasan (Janssen Research and Development) ; Hotopf, Matthew (King's College London) ; Dobson, Richard J. B. (University College London) ; Narayan, Vaibhav A. (Davos Alzheimer's Collaborative) ; La Porta, Maria Libera (University Vita-Salute and Hospital San Raffaele) ; Costa, Gloria Dalla (University Vita-Salute and Hospital San Raffaele) ; Magyari, Melinda (Copenhagen University Hospital Rigshospitalet) ; Sørensen, Per Soelberg (Copenhagen University Hospital Rigshospitalet) ; Nos, Carlos (Hospital Universitari Vall d'Hebron) ; Bailón, Raquel (Universidad de Zaragoza) ; Comi, Giancarlo (Casa di Cura del Policlinico (Milà, Itàlia))
The aim of this study was to investigate the feasibility of automatically assessing the 2-Minute Walk Distance (2MWD) for monitoring people with multiple sclerosis (pwMS). For 154 pwMS, MS-related clinical outcomes as well as the 2MWDs as evaluated by clinicians and derived from accelerometer data were collected from a total of 323 periodic clinical visits. [...]
2023 - 10.3390/s23136017
Sensors (Basel, Switzerland), Vol. 23 (june 2023)  
4.
10 p, 1.1 MB The Multiple Sclerosis Care Unit / Sørensen, Per S (Copenhagen University Hospital) ; Giovannoni, Gavin (Queen Mary University of London) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Thalheim, Christoph (European Multiple Sclerosis Platform, Brussels) ; Zaratin, Paola (Multiple Sclerosis International Federation (MSIF)) ; Comi, Giancarlo (San Raffaele Hospital, Milan) ; Universitat Autònoma de Barcelona. Departament de Medicina
Treatment of multiple sclerosis (MS) has become increasingly multifaceted and comprises not only a variety of disease-modifying drugs with different mechanism of action but also a wide range of symptomatic therapies. [...]
2019 - 10.1177/1352458518807082
Multiple sclerosis, Vol. 25 Núm. 5 (april 2019) , p. 627-636  
5.
9 p, 570.9 KB Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis : An Integrated Analysis of Safety / Giovannoni, Gavin (Queen Mary University of London) ; Galazka, Andrew (Merck. Aubonne. Switzerland. a division of Merck KGaA) ; Schick, Regina (Merck KGaA) ; Leist, Thomas (Jefferson University) ; Comi, Giancarlo (Università Vita-Salute San Raffaele. Ospedale San Raffaele) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Damian, Doris (EMD Serono Research and Development Institute. Inc) ; Dangond, Fernando (EMD Serono Research and Development Institute. Inc) ; Cook, Stuart (The State University of New Jersey) ; Universitat Autònoma de Barcelona. Departament de Medicina
Introduction: Although use of contraception was pre-specified during cladribine clinical trials for multiple sclerosis, some pregnancies did occur. Objective: This analysis reports on pregnancy outcomes in the cladribine clinical development program. [...]
2020 - 10.1007/s40264-020-00948-x
Drug Safety, Vol. 43 Núm. 7 (july 2020) , p. 635-643  
6.
11 p, 1.1 MB Safety of cladribine tablets in the treatment of patients with multiple sclerosis : An integrated analysis / Cook, Stuart (Rutgers. The State University of New Jersey) ; Leist, Thomas (Jefferson University) ; Comi, Giancarlo (Università Vita-Salute San Raffaele) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Giovannoni, Gavin (Queen Mary University of London) ; Nolting, Axel (Merck KGaA) ; Hicking, Christine (Merck KGaA) ; Galazka, Andrew (Merck. Zone Industrielle de L'Ouriettaz) ; Sylvester, Elke (Merck KGaA) ; Universitat Autònoma de Barcelona. Departament de Medicina
Background: Treating patients with relapsing multiple sclerosis (MS) with cladribine tablets (two times 4 or 5 days of treatment each year for 2 years) results in long-lasting efficacy, with continued stability in many patients for 4 or more years. [...]
2019 - 10.1016/j.msard.2018.11.021
Multiple Sclerosis and Related Disorders, Vol. 29 (april 2019) , p. 157-167  
7.
8 p, 915.8 KB Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis / Leist, Thomas (Jefferson University) ; Cook, S. (New Jersey Medical School) ; Comi, Giancarlo (Università Vita-Salute San Raffaele) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Giovannoni, Gavin (Queen Mary University of London) ; Nolting, A. (Merck KGaA) ; Damian, D. (Merck KGaA) ; Syed, S. (Merck KGaA) ; Galazka, Andrew (Merck KGaA) ; Universitat Autònoma de Barcelona
Background: Long-term safety data are of particular interest for any newly approved treatment in multiple sclerosis such as cladribine tablets 10 mg (MAVENCLAD®; 3. 5 mg/kg cumulative dose over 2 years, referred to as cladribine tablets 3. [...]
2020 - 10.1016/j.msard.2020.102572
Multiple Sclerosis and Related Disorders, Vol. 46 (november 2020) , p. 102572  
8.
10 p, 683.9 KB Ozanimod in relapsing multiple sclerosis : Pooled safety results from the clinical development program / Selmaj, Krzysztof W. (University of Warmia and Mazury) ; Cohen, Jeffrey A. (Neurological Institute) ; Comi, Giancarlo (Vita-Salute San Raffaele University) ; Bar-Or, Amit (University of Pennsylvania) ; Arnold, Douglas Lorne (McGill University) ; Steinman, Lawrence (Stanford University Medical Center) ; Hartung, Hans-Peter (Medical University Vienna) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Kubala Havrdova, Eva (Charles University) ; Cree, Bruce A. C (UCSF University of California San Francisco) ; Minton, Neil (Bristol Myers Squibb) ; Sheffield, James K. (Bristol Myers Squibb) ; Ding, Ning (Bristol Myers Squibb) ; Kappos, Ludwig (University of Basel) ; Universitat Autònoma de Barcelona
Background: Ozanimod, an oral sphingosine 1-phosphate receptor 1 and 5 modulator, is approved in multiple countries for the treatment of relapsing multiple sclerosis (RMS). In phase 3 trials, ozanimod was well tolerated and superior to interferon beta-1a 30 µg once-weekly in reducing clinical and radiologic disease activity. [...]
2021 - 10.1016/j.msard.2021.102844
Multiple Sclerosis and Related Disorders, Vol. 51 (june 2021) , p. 102844  
9.
13 p, 1.3 MB Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal / Thompson, Alan (University College London) ; Carroll, William ; Ciccarelli, Olga ; Comi, Giancarlo ; Cross, Anne H. ; Donnelly, Alexis A. ; Feinstein, Anthony ; Fox, Robert J ; Helme, Anne ; Hohlfeld, Reinhard ; Hyde, Robert ; Kanellis, Pamela ; Landsman, Douglas ; Lubetzki, Catherine ; Marrie, Ruth Ann ; Morahan, Julia ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Musch, Bruno ; Rawlings, Sarah ; Salvetti, Marco ; Sellebjerg, Finn ; Sincock, Caroline ; Smith, Kathryn E ; Strum, Jon ; Zaratin, Paola ; Coetzee, Timothy ; Universitat Autònoma de Barcelona
Progressive forms of multiple sclerosis (MS) affect more than 1 million individuals globally. Recent approvals of ocrelizumab for primary progressive MS and siponimod for active secondary progressive MS have opened the therapeutic door, though results from early trials of neuroprotective agents have been mixed. [...]
2021 - 10.1177/13524585211059766
Multiple sclerosis, Vol. 28 (december 2021) , p. 16-28  
10.
19 p, 537.2 KB Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis : Up to 5 years of follow-up in the DAYBREAK open-label extension trial / Cree, Bruce A. C (University of California) ; Selmaj, Krzysztof W. (University of Warmia and Mazury in Olsztyn) ; Steinman, Lawrence (Stanford University) ; Comi, Giancarlo (Vita-Salute San Raffaele University) ; Bar-Or, Amit (University of Pennsylvania) ; Arnold, Douglas Lorne (McGill University) ; Hartung, Hans-Peter (Medical University of Vienna) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Kubala Havrdova, Eva (Charles University) ; Sheffield, James K. (Bristol-Myers Squibb Company) ; Minton, Neil (Bristol-Myers Squibb Company) ; Cheng, Chun Yen (Bristol-Myers Squibb Company) ; Silva, Diego (Bristol-Myers Squibb Company) ; Kappos, Ludwig (University of Basel) ; Cohen, Jeffrey A. (Cleveland Clinic) ; Universitat Autònoma de Barcelona
Background: Ozanimod, an oral sphingosine 1-phosphate receptor 1 and 5 modulator, is approved in multiple countries for treatment of relapsing forms of MS. Objective: To characterize long-term safety and efficacy of ozanimod. [...]
2022 - 10.1177/13524585221102584
Multiple sclerosis, Vol. 28 Núm. 12 (2022) , p. 1944-1962  

Articles : 15 registres trobats   1 - 10següent  anar al registre:
Vegeu també: autors amb noms similars
1 Comi, G.P.
17 Comi, Giancarlo
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.